203 related articles for article (PubMed ID: 25924901)
1. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
Trinh B; Ko SY; Haria D; Barengo N; Naora H
Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
[TBL] [Abstract][Full Text] [Related]
2. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
Haria D; Trinh BQ; Ko SY; Barengo N; Liu J; Naora H
Am J Pathol; 2015 Aug; 185(8):2298-308. PubMed ID: 26067154
[TBL] [Abstract][Full Text] [Related]
3. A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2.
Hara F; Samuel S; Liu J; Rosen D; Langley RR; Naora H
Am J Pathol; 2007 May; 170(5):1594-606. PubMed ID: 17456765
[TBL] [Abstract][Full Text] [Related]
4. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
5. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Schiavone N; Vannacci A; Nistri S; Sardi I; Baroni G; Marzocca C; Perna F; Mazzanti R; Bechi P; Masini E
Am J Pathol; 2003 Mar; 162(3):793-801. PubMed ID: 12598314
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
[TBL] [Abstract][Full Text] [Related]
9. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
[TBL] [Abstract][Full Text] [Related]
11. The role of tumour-derived iNOS in tumour progression and angiogenesis.
Kostourou V; Cartwright JE; Johnstone AP; Boult JK; Cullis ER; Whitley G; Robinson SP
Br J Cancer; 2011 Jan; 104(1):83-90. PubMed ID: 21139581
[TBL] [Abstract][Full Text] [Related]
12. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
[TBL] [Abstract][Full Text] [Related]
13. Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor.
Dong J; Cheng M; Sun H
Mol Med Rep; 2014 Feb; 9(2):583-9. PubMed ID: 24297386
[TBL] [Abstract][Full Text] [Related]
14. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.
Lu T; Wu B; Yu Y; Zhu W; Zhang S; Zhang Y; Guo J; Deng N
Cancer Sci; 2018 Jul; 109(7):2221-2234. PubMed ID: 29737581
[TBL] [Abstract][Full Text] [Related]
15. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
16. Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways.
Shen A; Lin J; Chen Y; Lin W; Liu L; Hong Z; Sferra TJ; Peng J
Oncol Rep; 2013 Oct; 30(4):1701-6. PubMed ID: 23843018
[TBL] [Abstract][Full Text] [Related]
17. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli.
Sareila O; Hämäläinen M; Nissinen E; Kankaanranta H; Moilanen E
J Pharmacol Exp Ther; 2008 Feb; 324(2):858-66. PubMed ID: 18039960
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Chen CW; Chang YH; Tsi CJ; Lin WW
J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
[TBL] [Abstract][Full Text] [Related]
19. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G
Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030
[TBL] [Abstract][Full Text] [Related]
20. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
